Literature DB >> 26794910

Roles of CD48 in regulating immunity and tolerance.

Shannon L McArdel1, Cox Terhorst2, Arlene H Sharpe3.   

Abstract

CD48, a member of the signaling lymphocyte activation molecule family, participates in adhesion and activation of immune cells. Although constitutively expressed on most hematopoietic cells, CD48 is upregulated on subsets of activated cells. CD48 can have activating roles on T cells, antigen presenting cells and granulocytes, by binding to CD2 or bacterial FimH, and through cell intrinsic effects. Interactions between CD48 and its high affinity ligand CD244 are more complex, with both stimulatory and inhibitory outcomes. CD244:CD48 interactions regulate target cell lysis by NK cells and CTLs, which are important for viral clearance and regulation of effector/memory T cell generation and survival. Here we review roles of CD48 in infection, tolerance, autoimmunity, and allergy, as well as the tools used to investigate this receptor. We discuss stimulatory and regulatory roles for CD48, its potential as a therapeutic target in human disease, and current challenges to investigation of this immunoregulatory receptor.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD244; CD48; SLAM family

Mesh:

Substances:

Year:  2016        PMID: 26794910      PMCID: PMC4860950          DOI: 10.1016/j.clim.2016.01.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  145 in total

1.  Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity.

Authors:  N Mavaddat; D W Mason; P D Atkinson; E J Evans; R J Gilbert; D I Stuart; J A Fennelly; A N Barclay; S J Davis; M H Brown
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

2.  Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice.

Authors:  Marton Keszei; Yvette E Latchman; Vijay K Vanguri; Daniel R Brown; Cynthia Detre; Massimo Morra; Carolina V Arancibia-Carcamo; Carolina V Arancibia; Elahna Paul; Silvia Calpe; Wilson Castro; Ninghai Wang; Cox Terhorst; Arlene H Sharpe
Journal:  Int Immunol       Date:  2011-01-28       Impact factor: 4.823

3.  Characterization of genomic polymorphism of an activation-associated antigen, Blast-1.

Authors:  Y Matsui; K Shibano; H Kashiwagi; K Yamakawa-Kobayashi; H Inoko; D E Staunton; D A Thorley-Lawson
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

4.  Letter: Fatal infectious mononucleosis in familial lymphohistiocytosis.

Authors:  D T Purtilo; C Cassel; J P Yang
Journal:  N Engl J Med       Date:  1974-10-03       Impact factor: 91.245

5.  A critical role for CD48 antigen in regulating alloengraftment and lymphohematopoietic recovery after bone marrow transplantation.

Authors:  B R Blazar; P A Taylor; A Panoskaltsis-Mortari; H Yagita; J S Bromberg; D A Vallera
Journal:  Blood       Date:  1998-12-01       Impact factor: 22.113

6.  Identification of the 2B4 molecule as a counter-receptor for CD48.

Authors:  Y Latchman; P F McKay; H Reiser
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

7.  The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes.

Authors:  L Morel; K R Blenman; B P Croker; E K Wakeland
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

8.  Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates.

Authors:  Tim A Weaver; Ali H Charafeddine; Avinash Agarwal; Alexandra P Turner; Maria Russell; Frank V Leopardi; Robert L Kampen; Linda Stempora; Mingqing Song; Christian P Larsen; Allan D Kirk
Journal:  Nat Med       Date:  2009-07-05       Impact factor: 53.440

9.  Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D.

Authors:  C N Metz; G Brunner; N H Choi-Muira; H Nguyen; J Gabrilove; I W Caras; N Altszuler; D B Rifkin; E L Wilson; M A Davitz
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

10.  Macrophages lift off surface-bound bacteria using a filopodium-lamellipodium hook-and-shovel mechanism.

Authors:  Jens Möller; Tessa Lühmann; Mamta Chabria; Heike Hall; Viola Vogel
Journal:  Sci Rep       Date:  2013-10-07       Impact factor: 4.379

View more
  54 in total

1.  2B4-SAP signaling is required for the priming of naive CD8+ T cells by antigen-expressing B cells and B lymphoma cells.

Authors:  Yu-Hsuan Huang; Kevin Tsai; Sara Y Tan; Sohyeong Kang; Mandy L Ford; Kenneth W Harder; John J Priatel
Journal:  Oncoimmunology       Date:  2016-12-27       Impact factor: 8.110

2.  Anti-CD48 Monoclonal Antibody Attenuates Experimental Autoimmune Encephalomyelitis by Limiting the Number of Pathogenic CD4+ T Cells.

Authors:  Shannon L McArdel; Daniel R Brown; Raymond A Sobel; Arlene H Sharpe
Journal:  J Immunol       Date:  2016-08-31       Impact factor: 5.422

Review 3.  Hematopoietic stem and progenitor cells directly participate in host immune response.

Authors:  Olusola Jumoke Daramola; Stephen Osasan; Hebah Ali; Perpetua Emeagi
Journal:  Am J Stem Cells       Date:  2021-06-15

4.  Co-inhibitory profile and cytotoxicity of CD57+ PD-1- T cells in end-stage renal disease patients.

Authors:  R Kraaijeveld; G N de Graav; M Dieterich; N H R Litjens; D A Hesselink; C C Baan
Journal:  Clin Exp Immunol       Date:  2017-11-09       Impact factor: 4.330

5.  Identification of human endogenous retrovirus transcripts in Hodgkin Lymphoma cells.

Authors:  Marie Barth; Victoria Gröger; Holger Cynis; Martin Sebastian Staege
Journal:  Mol Biol Rep       Date:  2019-02-01       Impact factor: 2.316

6.  Human innate lymphoid cell precursors express CD48 that modulates ILC differentiation through 2B4 signaling.

Authors:  Dejene M Tufa; Ashley M Yingst; George Devon Trahan; Tyler Shank; Dallas Jones; Seonhui Shim; Jessica Lake; Kevin Winkler; Laura Cobb; Renee Woods; Kenneth Jones; Michael R Verneris
Journal:  Sci Immunol       Date:  2020-11-20

7.  Enhanced NLRP3 and DEFA1B Expression During the Active Stage of Parenchymal Neuro-Behçet's Disease.

Authors:  Elif Ugurel; Ece Erdag; Cem Ismail Kucukali; Ayca Olcay; Elif Sanli; Ece Akbayir; Murat Kurtuncu; Tuncay Gunduz; Vuslat Yilmaz; Erdem Tuzun; Burcak Vural
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

8.  CD48 and α7 Nicotinic Acetylcholine Receptor Synergistically Regulate FimH-Mediated Escherichia coli K1 Penetration and Neutrophil Transmigration Across Human Brain Microvascular Endothelial Cells.

Authors:  Rui Liu; Chao Wu; Li Li; Feng Chi; Tiesong Zhang; Yating Xu; Lulu Ji; Zhiguo Chen; Hanyang Hu; Xiaoli Zhang; Shenghe Huang; Lin Wang
Journal:  J Infect Dis       Date:  2019-01-09       Impact factor: 5.226

Review 9.  SLAMF6 in health and disease: Implications for therapeutic targeting.

Authors:  Burcu Yigit; Ninghai Wang; Roland W Herzog; Cox Terhorst
Journal:  Clin Immunol       Date:  2018-10-23       Impact factor: 3.969

10.  FOXP3 protects conventional human T cells from premature restimulation-induced cell death.

Authors:  Kelsey Voss; Camille Lake; Christopher R Luthers; Nathaniel M Lott; Batsukh Dorjbal; Swadhinya Arjunaraja; Bradly M Bauman; Anthony R Soltis; Gauthaman Sukumar; Clifton L Dalgard; Andrew L Snow
Journal:  Cell Mol Immunol       Date:  2019-10-28       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.